New ocular steroid

Blepharitis is the medical term for inflamed eyelids. The inflammation is like eczema of the skin, with red, scaly eyelids. You may notice tired, or gritty eyes, which may be uncomfortable in sunlight or a smoky atmosphere. They may be slightly red, and feel as though there is something in them. The eyelids have tiny glands in them, especially the lower lids. These glands make substances that mix with tears, and help the tears to spread across the eye. There may be fungi in the lids Eye 15 , or demodex mite.

Pearls for Use
We practitioners are fortunate to have so many topical steroids available now. So, don’t rely on one “go-to” drug for all presenting conditions. Pick your drug based on the amount of inflammation you’re treating: mild, moderate or severe. Mild surface inflammation is easily treated with less penetrating drugs such as Alrex or FML, which typically help avoid the steroid response. Moderate inflammation is handled well with Lotemax or Vexol, while Pred Forte or Durezol should be reserved as treatment for severe inflammation. Many generic topical steroids are also now available for patients with financial concerns.

The following microorganisms are considered susceptible when evaluated using systemic breakpoints. However, a correlation between the in vitro systemic breakpoint and ophthalmological efficacy has not been established. This list of microorganisms is provided as an aid only in assessing the potential treatment of conjunctival infections. Azithromycin exhibits in vitro minimal inhibitory concentrations (MICs) of equal or less (systemic susceptible breakpoint) against most (≥90%) of isolates of the following ocular pathogens: Chlamydia pneumoniae Chlamydia trachomatis Legionella pneumophila Moraxella catarrhalis Mycoplasma hominis Mycoplasma pneumoniae Neisseria gonorrhoeae Peptostreptococcus species Streptococci (Groups C, F, G) Streptococcus pyogenes Streptococcus agalactiae Ureaplasma urealyticum Viridans group streptococci

New ocular steroid

new ocular steroid


new ocular steroidnew ocular steroidnew ocular steroidnew ocular steroidnew ocular steroid